6. Miscellaneous Others
Sheng Li,G. Breen,N. Gu,G. Feng,Wanqing Liu,S. Bai,Jiangang Zhang,T. Shen,D. Clair
DOI: https://doi.org/10.1038/sj.mp.4000630
IF: 11
1999-01-01
Molecular Psychiatry
Abstract:S102 are involved in the early regionalization of the embyo brain and may play a role in the differentiation, maintenance, and functional assembly of specific subsets of cells in the adult brain. We have isolated and characterized the 59 flanking regions of both genes. In the PAX-3 gene, a polymorphic (CA)13–31 repeat was found at nt position −337. The (CA)25 variant confers a significantly lower transcriptional efficiency on the PAX-3 gene promoter. In the PAX-7 gene promoter, a polymorphic (CCT)8–11 repeat sequence is located directly upstream of the proximal start site. In cell transfection assays with the PAX-7 gene promoter, no differences in transcriptional efficiency between different alleles were found. Previously, a contribution of polymorphic repeats in brain expressed genes to behavioural and personality differences among individuals have been reported; therefor, we have genotyped a sample of patients with psychiatric disorders for the gene variants described here. A moderately lower abundance (Wilcoxon’s test: p=0.02) was found for the the PAX-3 promoter 25 repeat allele in a sample of the paranoid subtype of schizophrenia (|9%; n=164 alleles) compared to a control sample (|16%; n=444 alleles), but not with other psychiatric disorders (other schizophrenia subtypes: n=382 alleles, affective disorders: n=292 alleles). Compared to our previous findings for the PAX-6 promoter repeats, the PAX-3/PAX-7 variants described here seem to be of limited importance for the genesis of psychiatric disorders. 250. TRINUCLEOTIDE REPEAT FOR SCA8 ON 13q21: “SUPER” EXPANSION IN PSYCHOTIC INDIVIDUALS UNAFFECTED BY ATAXIA. Vincent JB, Neves-Pereira ML, Paterson AD, Yamamoto E, Parikh SV, Macciardi F, Petronis A, and Kennedy JL.. Department of Genetics, The Hospital for Sick Children, Neurogenetics Section and Bipolar Clinic, Clarke Division, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON. Increased frequency of large CAG/CTG trinucleotide repeat tracts in individuals affected with schizophrenia (SCZ) and bipolar affective disorder (BPAD) has previously been reported. Studies of two unstable CAG/CTG repeats (SEF1–2B and ERDA1) indicate that the majority of individuals with large repeats (detected by RED) have large repeat alleles at these loci, but that there is no association of large alleles with either BPAD or SCZ. Using RED, we have identified from amongst our sample a BPAD individual with a very large (.690bp) trinucleotide repeat tract at a third site. From this individual’s DNA, we have cloned a new highly polymorphic trinucleotide repeat, TGC13–7a, comprised of [TAC]a [TGC]n, which is expanded (|1800bp) in this patient. The repeat region localizes to chromosome 13q21, and has recently been reported to be the cause of spinocerebellar ataxia type 8, where alleles with greater than |107 repeats are thought to be pathogenic. We observed no significant differences in allele distribution between 100 BPAD patients and 100 matched controls (p=0.06), and no transmission disequilibrium in 93 BPAD trios (p=0.49) or 54 SCZ trios (p=0.46). We have now identified a number of other individuals with very large expansions at TGC13–7a/SCA8: a SCZ individual with |550 repeats, a SCZ individual with 115 repeats and unaffected father with |700 repeats, none of whom are affected by spinocerebellar ataxia. Whilst these expansions are relatively rare (|0.5% of all individuals tested), it is clearly much more common than the frequency of all spinocerebellar ataxia cases (0.01%), let alone SCA8. “Super” expansions at TGC13–7a/SCA8 may be allelic variants that predispose to psychosis via a different molecular mechanism compared to the more modest expansion alleles reported for SCA8. Alternatively this expansion may be completely unrelated to psychosis. 251. ISOLATION OF GENES CONTAINING TRINUCLEOTIDE REPEAT EXPANSION. Yuan QP, Lindblad K, Schalling M.. Neurogenetics Unit, Center for Molecular Medicine, Karolinska Hospital, 17176 Stockholm, Sweden. Anticipation, an increase of disease severity and decrease of age-of-onset in successive generations within a family, is a hallmark of trinucleotide repeat disorders. Independent studies have reported evidence of anticipation in psychiatric disorders, e.g. bipolar affective disorder and schizophrenia, suggesting the involvement of triplet repeat in the ctiology of disease. We have developed an isolation strategy for DNA fragments containing enlarged repeat sequences. Sucrose gradient and denaturing gradient gel electrophoresis (DGGE) or agarose gel electrophoresis are used to enrich the target fragments from digested genomic DNA. The enriched DNA fragments are then cloned into Zap-Express vector to isolate the single clones carrying the expanded repeat sequence. The repeat expansion detection (RED) method is used to follow the repeat throughout the whole procedure. Stringent hybridization conditions enabled us to isolate single clones containing long repeat sequences. This isolation strategy has been applied to the cloning of long repeat containing fragments in a time-effective manner, starting with DNA from an individual having expanded triplet repeat. Once a disease is found to be associated with an unknown triplet repeat expansion, cloning of the gene can be achieved within months using this strategy. 6. Miscellaneous Others 252. NEUROTENSIN AND ITS RECEPTOR IN SCHIZOPHRENIA AND BIPOLAR DISORDER. Austin J Hoogendoorn B Buckland P Middle F Williams N Craddock N McGuffin P Owen MJ O’Donovan MC. 1. Department of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, UK, CF4 4XN 2. Division of Neuroscience, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Birmingham, B15 2QZ 3. SGDP Research Center, Institute of Psychiatry, London SE5 8AF. Both neurotensin and its receptor are widely distributed throughout the CNS, predominately in regions enervated by, or associated with, dopaminergic neurones. There is now a large body of biochemical, behavioural and electrophysiological evidence showing that the neurotensin neurotransmission system interacts closely with dopaminergic neurotransmission, and therefore neurotensin and its receptor have been proposed as candidate genes for psychosis. We have used the WAVE Denaturing High Performance Liquid Chromatography (DHPLC) system to screen 1381 bases of the proneurotensin gene and 2306 bases of the neurotensin receptor gene for common sequence variation in 14 unrelated people with schizophrenia and 14 unrelated people with bipolar disorder. The entire coding regions of both genes were screened, together with 283 bases of the 5’ flanking region of the neurotensin gene and 772 bases of the promoter region of